论文部分内容阅读
宫颈癌是危害妇女健康的重大疾病之一,死亡率逐年上升,且有年轻化趋势。筛查是宫颈癌防治的关键手段,理想的筛查方法必须满足疾病进展各个阶段的临床需求。高危型人乳头瘤病毒(HPV)基因检测可用于一线初筛:高危型基因检测在浸润癌筛查方面,具有客观、快速、敏感性高、可重复性高等优点。HPV疫苗上市,并不意味着未来不需要宫颈癌筛查。在HPV初筛和联合细胞学双筛策略中,
Cervical cancer is one of the major diseases endangering the health of women. The mortality rate is increasing year by year and tends to be younger. Screening is a key tool in the prevention and treatment of cervical cancer, and the ideal screening method must meet the clinical needs of all stages of disease progression. High-risk human papillomavirus (HPV) gene test can be used for first-line screening: high-risk gene testing in invasive cancer screening, with objective, rapid, high sensitivity, high reproducibility. HPV vaccine market, does not mean that the future does not require cervical cancer screening. In the HPV screening and combined cytology two-screen strategy,